PICOLINAMIDE AND PYRIMIDINE-4-CARBOXAMIDE COMPOUNDS, METHOD OF OBTAINING THEREOF AND THEREOF-CONTAINING PHARMACEUTICAL COMPOSITION Russian patent published in 2015 - IPC C07D401/04 C07D401/14 C07D413/14 A61K31/444 A61K31/496 A61K31/5377 A61P1/18 A61P3/04 A61P3/06 A61P3/08 A61P9/00 A61P37/00 

Abstract RU 2566827 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: in formula 1 X represents N or CR, and Y represents N or CH on condition that X and Y are not simultaneously carbon; Z represents N or CH; R1 and R2 represent independently hydrogen, (C3-C10)cycloalkyl, norbornyl, adamantyl or noradamantyl, or R1 and R2 can be bound with each other together with nitrogen atoms, to which they are bound, with the formation of (C5-C10) saturated or unsaturated heterocycle or condensed heterocycle, on condition that R1 and R2 are not simultaneously hydrogen; L represents a single bond, -CO-, -SO2-, -(CR21R22)-(CH2)c- (c represents an integer number 0-5), , -CO(CR21R22)d- (d represents an integer number 1-6), (C3-C10)cycloalkylene, (C6-C20)arylene or 5-6-membered heteroarylene, including one or two heteroatoms, selected from N; R21 and R22 represent independently hydrogen or (C1-C10)alkyl, R represents hydrogen or hydroxyl; R4 and R5 independently represent hydrogen or (C1-C10)alkyl, or R4 and R5, bound together form a 6-membered unsaturated carbocycle; R6 and R7 represent independently hydrogen, (C1-C10)alkyl or halogen; R31-R38, R41-R43 and R46 represent independently hydrogen or (C1-C10)alkyl; and m and n independently represent an integer number 0-3 on condition that m+n represent an integer number 2 or larger. Values of radical R3 and additional substituents of cyclic groups R1-R3, L are given in the invention formula. The invention also relates to pharmaceutical composition, containing the said compounds, and to the 11β-HSD1 inhibitor.

.

EFFECT: invention relates to amide compounds of structural formula 1, which possess inhibiting activity with respect to 11β-HSD1 enzyme.

9 cl, 24 tbl, 296 ex

Similar patents RU2566827C2

Title Year Author Number
DERIVATIVES OF PYRROLOPYRIMIDINE, METHOD FOR PREPARING AND THEIR USING 2001
  • Kim Dae-Kee
  • Li Dzu Jang
  • Riu Do Khiun
  • Li Nam Kiu
  • Li Suk Kho
  • Kim Nam-Kho
  • Kim Dzae-Sun
  • Riu Dze Kho
  • Choj Dzin-Jang
  • Im Guang-Dzin
  • Choj Von-Son
  • Kim Tae Kon
  • Cha Khoon
RU2263676C2
2-PYRIDYL SUBSTITUTED IMIDAZOLES AS ALK5 AND/OR ALK4 INHIBITORS 2012
RU2612958C2
NEW PYRIDINE DERIVATIVES, METHOD FOR MAKING THEREOF AND RELATED PHARMACEUTICAL COMPOSITION 2004
  • Kim Khiung-Ook
  • Li Nam Kiu
  • Kim Dzoo Khion
  • Rkhee Khae In
  • Cho Jong-Baik
  • Riu Dze Kho
  • Kim Nam Kho
  • Riu Keun Kho
  • Ji Dzung Bum
  • Dzung Dzae Joon
RU2366659C2
TRICYCLIC NITROGEN-CONTAINING DERIVATIVES OF IMIDAZO[4,5-C]PYRIDINE, HAVING INHIBITING ACTIVITY IN RESPONSE TO HYSTAMINE 4 RECEPTOR (HH4R) 2012
  • Kho Pil Su
  • Joon Dong Okh
  • Khan Sun Joung
  • Li Von Il
  • Kim Dzung Sook
  • Park Voul Seong
  • Akhn Sung Okh
  • Kim Khie Dzung
RU2628074C2
NEW COMPOUNDS FOR SELECTIVE HISTONE DEACETYLASE INHIBITORS AND PHARMACEUTICAL COMPOSITION INCLUDING SUCH COMPOUNDS 2014
  • Li Changsik
  • Yang Khiun-Mo
  • Choj Khodzhin
  • Kim Dokhun
  • Kim Sojoung
  • Kha Nina
  • Lim Khiodzhin
  • Ko Eunkhi
  • Joon Seongae
  • Bae Daekvon
RU2634694C2
DERIVATIVES OF IMIDAZOLE ELICITING INHIBITORY ACTIVITY WITH RESPECT TO FARNESYLTRANSFERASE, METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION 1998
  • Li Khiun Il
  • Kokh Dzong Sung
  • Li Dzin Kho
  • Dzung Von Khi
  • Shin Ju Seung
  • Chung Khiun Kho
  • Kim Dzong Khiun
  • Ro Seong Gu
  • Choj Tae Saeng
  • Dzeong Shin Vu
  • Kvak Tae Khvan
  • Akhn In Ae
  • Kim Khiun Sung
  • Li Sun Khva
  • Kim Kvi Khva
  • Joo Dzung Kvon
RU2179975C1
COMPOUNDS AND COMPOSITIONS FOR MODULATING KINASE ACTIVITY OF EGFR MUTANTS 2015
  • Sukh, Biung-Chul
  • Salgaonkar, Paresh Devidas
  • Li, Dzhekyu
  • Kokh, Dzong Sung
  • Song, Kho-Dzun
  • Li, In Jong
  • Li, Dzhesang
  • Dzung, Dong-Sik
  • Kim, Dzung-Kho
  • Kim, Se-Von
RU2822389C2
NOVEL COMPOUNDS, ISOMERS THEREOF OR PHARMACUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUNDS 2007
  • Kim Sun-Jang
  • Kim Dzin Kvan
  • Li Ki-Vkha
  • Voo Bioung Jang
  • Shin Song Seog
  • Mokh Dzoo-Khiun
  • Kim Sung-Il
  • Dzeong Jeon Su
  • Lim Kiung Min
  • Choi Dzin Kiu
  • Kha Dzun Jong
  • Kokh Khiun-Dzu
  • Park Jang-Kho
  • Sukh Jang-Ger
  • Kim Khee-Doo
  • Park Khieung-Geun
  • Okh Ukh Taek
RU2448108C2
NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY 2011
  • Cha Mi Yang
  • Kang Seok Dzong
  • Kim Mi Ra
  • Li Dzu Jeon
  • Dzeon Dzi Yang
  • Dzo Mioung Gi
  • Kvak Eun Dzoo
  • Li Kvang Ok
  • Kha Tae Khee
  • Sukh Kvee Khiun
  • Kim Maeng Sup
RU2598852C2
MELANOCORTIN RECEPTOR AGONISTS 2007
  • Choi Sung Pil
  • Akhn In Ae
  • Li Sang Khjup
  • Li Sang Dae
  • Shin Mi Sook
  • Li Koo
  • Choj Deog Jang
  • Shim Dong Sup
  • Jim Khieon Dzoo
  • Joon Min Kiung
  • Chung Soo Jong
  • Li Dzung Ae
  • Kha Jong Khva
  • Kim Jang Kvan
  • Park Oeuk
  • Li Khiun Min
  • Kim Joun Khoa
RU2411240C2

RU 2 566 827 C2

Authors

Riu Dze Kho

Kim Shin Ae

Riu Keun Kho

Kim Dzae Sun

Kim Nam Kho

Khan Khie Jang

Kim Jong Khiuk

Joun Von-No

Li Joon-Dzung

Son Khiun Dzoo

Li Bong-Jong

Park Sung Khoon

Li Dzu Jang

Li Khiun Dzung

Dzung Khoe Chul

Shin Jang Akh

Li Dzung A.

Li Bo Ram

Sa Dzoon Kho

Dates

2015-10-27Published

2011-05-04Filed